These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8556836

  • 1. Changes in diurnal blood pressure variation and red cell and plasma volumes in patients with renal failure who develop erythropoietin-induced hypertension.
    Jones MA, Kingswood JC, Dallyn PE, Andrew M, Cheetham A, Burwood R, Sharpstone P.
    Clin Nephrol; 1995 Sep; 44(3):193-200. PubMed ID: 8556836
    [Abstract] [Full Text] [Related]

  • 2. [Effect of recombinant human erythropoietin administration on cardiovascular system in patient with chronic renal failure: an analysis of the blood pressure upward].
    Satoh K, Ikeda Y, Kurokawa S, Kamata K, Masuda T, Kikawada R, Marumo F.
    Kokyu To Junkan; 1989 Mar; 37(3):313-9. PubMed ID: 2734509
    [Abstract] [Full Text] [Related]

  • 3. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD, Baker LR, Raine AE.
    Clin Nephrol; 1993 Feb; 39(2):103-10. PubMed ID: 8448912
    [Abstract] [Full Text] [Related]

  • 4. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 5. [Continuous ambulatory measurement of blood pressure in children--personal experience].
    Peco-Antić A, Pejcić I, Stojanov V, Kostić M, Kruscić D, Jovanović O, Mancić J.
    Srp Arh Celok Lek; 1997 Oct; 125(7-8):197-202. PubMed ID: 9304231
    [Abstract] [Full Text] [Related]

  • 6. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
    Covic A, Mititiuc I, Gusbeth-Tatomir P, Goldsmith DJ.
    J Nephrol; 2002 Oct; 15(5):497-506. PubMed ID: 12455715
    [Abstract] [Full Text] [Related]

  • 7. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 8. [Influence of blood pressure profile on erythropoietin levels in diabetics].
    Mayaudon H, Dupuy O, Dolz M, Bordier L, Belmejdoub G, Garcin JM, Bauduceau B.
    Arch Mal Coeur Vaiss; 2002 Dec; 95(7-8):743-6. PubMed ID: 12365091
    [Abstract] [Full Text] [Related]

  • 9. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R, Steffen HM, Brunner R, Saric J, Pollok M, Baldamus CA, Kaufmann W.
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [Abstract] [Full Text] [Related]

  • 10. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 11. Analysis of factors that affect short-term blood pressure variability in patients with chronic renal failure.
    Sakai M, Tamura K, Tanaka Y, Tsurumi Y, Okano Y, Koide Y, Endoh T, Matsushita K, Kihara M, Hirawa N, Toya Y, Tokita Y, Ohnishi T, Umemura S.
    Clin Exp Hypertens; 2005 Mar; 27(2-3):139-47. PubMed ID: 15835376
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M, Umezu M, Nagano M, Tagawa H.
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [Abstract] [Full Text] [Related]

  • 13. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 14. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
    Singh NP, Chandrashekhar, Nair M, Anuradha S, Kohli R, Agarwal SK.
    J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
    [Abstract] [Full Text] [Related]

  • 15. Ambulatory blood pressure monitoring in hemodialysis patients.
    Elisaf M, Pappas H, Kalaitzidis R, Katopodis K, Theodorou J, Siamopoulos KG.
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S43-7. PubMed ID: 8872825
    [Abstract] [Full Text] [Related]

  • 16. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Sep; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 17. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 18. [Influence of blood pressure level on urinary albumin excretion rate and erythropoietin production in diabetic patients].
    Bordier L, Le Berre JP, Garcia C, Dupuy O, Mayaudon H, Bauduceau B.
    Arch Mal Coeur Vaiss; 2006 May; 99(7-8):701-4. PubMed ID: 17061448
    [Abstract] [Full Text] [Related]

  • 19. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [Abstract] [Full Text] [Related]

  • 20. Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?
    de Fijter CW, Popp-Snijders C, Oe LP, Tran DD, van der Meulen J, Donker AJ.
    Haematologica; 1995 Mar; 80(4):332-4. PubMed ID: 7590502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.